These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37756050)

  • 1. Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies.
    Khanna A; Jones G
    JMIR Form Res; 2023 Sep; 7():e47486. PubMed ID: 37756050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle Interventions for the Prevention of Parkinson Disease: A Recipe for Action.
    Janssen Daalen JM; Schootemeijer S; Richard E; Darweesh SKL; Bloem BR
    Neurology; 2022 Aug; 99(7 Suppl 1):42-51. PubMed ID: 35970584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    Oertel W; Schulz JB
    J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
    Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
    JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational drug discovery design approaches for treating Parkinson's disease.
    Van der Schyf CJ
    Expert Opin Drug Discov; 2015 Jul; 10(7):713-41. PubMed ID: 26054694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropsychiatric manifestations in Parkinson's disease].
    Oikonomou E; Paparrigopoulos T
    Psychiatriki; 2015; 26(2):116-30. PubMed ID: 26197101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.
    Jones-Tabah J
    J Mol Biol; 2023 Jun; 435(12):167927. PubMed ID: 36563742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies.
    Weintraub D; Irwin D
    Continuum (Minneap Minn); 2022 Oct; 28(5):1314-1332. PubMed ID: 36222767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Treatment of Parkinson Disease: A Review.
    Armstrong MJ; Okun MS
    JAMA; 2020 Feb; 323(6):548-560. PubMed ID: 32044947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 16. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions.
    Biundo R; Fiorenzato E; Antonini A
    Int Rev Neurobiol; 2017; 133():389-415. PubMed ID: 28802926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update.
    Gouda NA; Elkamhawy A; Cho J
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203580
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.